NASDAQ:ALNY
Alnylam Pharmaceuticals Stock News
$150.47
-0.90 (-0.595%)
At Close: May 10, 2024
Is Alnylam a Good Biotech Stock to Buy Now? | The Motley Fool
12:23pm, Sunday, 21'st Jun 2020
This biotech could earn its third new drug approval in as many years.
Mackenzie Financial Corp Increases Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
07:22am, Sunday, 21'st Jun 2020
Mackenzie Financial Corp increased its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) by 31.1% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investo
Alnylam Pharmaceuticals : to Host Seventh Annual 'RNAi Roundtable' Webcast Series | MarketScreener
01:08pm, Friday, 19'th Jun 2020GNW: Sanofi présente les données intermédiaires positives de sécurité et | Zone bourse
01:01pm, Friday, 19'th Jun 2020
Sanofi announces positive long-term efficacy and safety data for fitusiran from interim analysis of Phase 2 extension study in people with hemophilia A and B,
The Global Biodefense Market will grow by $ 3.22 billion during 2020-2024
Alnylam Pharmaceuticals : to Host Seventh Annual “RNAi Roundtable” Webcast Series | MarketScreener
11:03am, Thursday, 18'th Jun 2020Alnylam to Host Seventh Annual "RNAi Roundtable" Webcast Series
11:00am, Thursday, 18'th Jun 2020
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 7th annual series of "RNAi Roundtable" webinars over the coming weeks. Th
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by APG Asset Management N.V.
08:08am, Thursday, 18'th Jun 2020
APG Asset Management N.V. decreased its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) by 76.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Co
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock Position Decreased by M&T Bank Corp
07:22am, Thursday, 18'th Jun 2020
M&T Bank Corp lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) by 10.6% in the first quarter, according to the company in its most recent filing with the Securities & Exc
Alnylam to Host Seventh Annual “RNAi Roundtable” Webcast Series
12:00am, Thursday, 18'th Jun 2020
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 7th annual series of “R
